157 related articles for article (PubMed ID: 38105242)
1. Development and psychometric evaluation of a physician global assessment for type 2 systemic lupus erythematosus symptoms.
Clowse MEB; Rogers JL; Coles T; Pisetsky DS; Criscione-Schreiber LG; Burshell D; Doss J; Sadun RE; Sun K; Maheswaranathan M; Eudy AM
Lupus Sci Med; 2023 Dec; 10(2):. PubMed ID: 38105242
[TBL] [Abstract][Full Text] [Related]
2. Fatigue is independently associated with disease activity assessed using the Physician Global Assessment but not the SLEDAI in patients with systemic lupus erythematosus.
Mertz P; Piga M; Chessa E; Amoura Z; Voll RE; Schwarting A; Maurier F; Blaison G; Bonnotte B; Poindron V; Fiehn C; Lorenz HM; Korganow AS; Sibilia J; Martin T; Arnaud L
RMD Open; 2022 Sep; 8(2):. PubMed ID: 36123013
[TBL] [Abstract][Full Text] [Related]
3. The use of patient-reported outcome measures to classify type 1 and 2 systemic lupus erythematosus activity.
Eudy AM; Reeve BB; Coles T; Lin L; Rogers JL; Pisetsky DS; Criscione-Schreiber LG; Doss J; Sadun R; Sun K; Clowse ME
Lupus; 2022 May; 31(6):697-705. PubMed ID: 35343853
[TBL] [Abstract][Full Text] [Related]
4. Addition of constitutional symptoms to the SLEDAI-2K improves overall disease activity assessment: A pilot study.
Anderson EW; Sansone M; Shah B; Kline M; Franchin G; Aranow C; Mackay M
Lupus; 2024 Jul; 33(8):840-850. PubMed ID: 38664230
[TBL] [Abstract][Full Text] [Related]
5. Use of Physician Global Assessment in systemic lupus erythematosus: a systematic review of its psychometric properties.
Chessa E; Piga M; Floris A; Devilliers H; Cauli A; Arnaud L
Rheumatology (Oxford); 2020 Dec; 59(12):3622-3632. PubMed ID: 32789462
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of Type 2 SLE symptoms in patients with a range of lupus nephritis activity.
Rogers JL; Clowse MEB; Pisetsky DS; Criscione-Schreiber LG; Sun K; Sadun RE; Maheswaranathan M; Burshell DR; Doss J; Eudy AM
Clin Rheumatol; 2024 Apr; 43(4):1319-1326. PubMed ID: 38409491
[TBL] [Abstract][Full Text] [Related]
7. Validity and reliability of retrospective assessment of disease activity and flare in observational cohorts of lupus patients.
FitzGerald JD; Grossman JM
Lupus; 1999; 8(8):638-44. PubMed ID: 10568901
[TBL] [Abstract][Full Text] [Related]
8. Patient and Physician Perspectives of Systemic Lupus Erythematosus Flare: A Qualitative Study.
Rogers JL; Clowse MEB; McKenna K; Starling S; Swezey T; Molokwu N; Corneli A; Pisetsky DS; Sun K; Criscione-Schreiber LG; Sadun RE; Maheswaranathan M; Burshell D; Doss J; Eudy AM
J Rheumatol; 2024 May; 51(5):488-494. PubMed ID: 38101916
[TBL] [Abstract][Full Text] [Related]
9. Using Clinical Characteristics and Patient-Reported Outcome Measures to Categorize Systemic Lupus Erythematosus Subtypes.
Rogers JL; Eudy AM; Pisetsky D; Criscione-Schreiber LG; Sun K; Doss J; Clowse MEB
Arthritis Care Res (Hoboken); 2021 Mar; 73(3):386-393. PubMed ID: 31909888
[TBL] [Abstract][Full Text] [Related]
10. Quantitative data for care of patients with systemic lupus erythematosus in usual clinical settings: a patient Multidimensional Health Assessment Questionnaire and physician estimate of noninflammatory symptoms.
Askanase AD; Castrejón I; Pincus T
J Rheumatol; 2011 Jul; 38(7):1309-16. PubMed ID: 21459938
[TBL] [Abstract][Full Text] [Related]
11. Associations between physicians' global assessment of disease activity and patient-reported outcomes in patients with systemic lupus erythematosus: A longitudinal study.
Louthrenoo W; Kasitanon N; Morand E; Kandane-Rathnayake R
Lupus; 2021 Sep; 30(10):1586-1595. PubMed ID: 34192957
[TBL] [Abstract][Full Text] [Related]
12. Lupus Impact Tracker is responsive to physician and patient assessed changes in systemic lupus erythematosus.
Giangreco D; Devilliers H; Annapureddy N; Block JA; Jolly M
Lupus; 2015 Dec; 24(14):1486-91. PubMed ID: 26162686
[TBL] [Abstract][Full Text] [Related]
13. Laboratory investigation results influence Physician's Global Assessment (PGA) of disease activity in SLE.
Aranow C; Askanase A; Oon S; Huq M; Calderone A; Morand EF; Nikpour M
Ann Rheum Dis; 2020 Jun; 79(6):787-792. PubMed ID: 32241797
[TBL] [Abstract][Full Text] [Related]
14. Using PROMIS-29 to determine symptom burdens in the context of the Type 1 and 2 systemic lupus erythematosus (SLE) model: a cross sectional study.
Sun K; Eudy AM; Harris N; Pisetsky DS; Criscione-Schreiber LG; Sadun RE; Doss J; Clowse MEB; Rogers JL
J Patient Rep Outcomes; 2023 Dec; 7(1):136. PubMed ID: 38127169
[TBL] [Abstract][Full Text] [Related]
15. Psychometric properties of fatigue severity scale in Chinese systemic lupus erythematosus patients.
Feng C; He Q; Wu Y; Hu X; Wu J; He X; Zhao S
Health Qual Life Outcomes; 2019 Apr; 17(1):71. PubMed ID: 31014340
[TBL] [Abstract][Full Text] [Related]
16. Reliability and validity of systemic lupus activity measure-revised (SLAM-R) for measuring clinical disease activity in systemic lupus erythematosus.
Bae SC; Koh HK; Chang DK; Kim MH; Park JK; Kim SY
Lupus; 2001; 10(6):405-9. PubMed ID: 11434575
[TBL] [Abstract][Full Text] [Related]
17. The Systemic Lupus Activity Measure-revised, the Mexican Systemic Lupus Erythematosus Disease Activity Index (SLEDAI), and a modified SLEDAI-2K are adequate instruments to measure disease activity in systemic lupus erythematosus.
Uribe AG; Vilá LM; McGwin G; Sanchez ML; Reveille JD; Alarcón GS
J Rheumatol; 2004 Oct; 31(10):1934-40. PubMed ID: 15468356
[TBL] [Abstract][Full Text] [Related]
18. Translation, cultural adaptation and validation of the Systemic Lupus Erythematosus Activity Questionnaire (SLAQ) in a cohort of Italian systemic lupus erythematosus patients.
Tani C; Vagelli R; Stagnaro C; Carli L; Lorenzoni V; Drago F; Doherty W; McSorley MR; Marconcini L; Della Rossa A; Turchetti G; Mosca M
Lupus; 2018 Sep; 27(10):1735-1741. PubMed ID: 30045666
[TBL] [Abstract][Full Text] [Related]
19. Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus.
Liang MH; Socher SA; Larson MG; Schur PH
Arthritis Rheum; 1989 Sep; 32(9):1107-18. PubMed ID: 2775320
[TBL] [Abstract][Full Text] [Related]
20. Psychometric properties of FACIT-Fatigue in systemic lupus erythematosus: a pooled analysis of three phase 3 randomised, double-blind, parallel-group controlled studies (BLISS-SC, BLISS-52, BLISS-76).
Rendas-Baum R; Baranwal N; Joshi AV; Park J; Kosinski M
J Patient Rep Outcomes; 2021 Apr; 5(1):33. PubMed ID: 33830377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
